CREB Antibodies

Santa Cruz Biotechnology features a diverse variety of CREB Antibodies for investigating cAMP response element-binding protein (CREB) in cellular processes. CREB Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CREB functions as a transcription factor that regulates gene expression in response to cellular signals, playing a vital role in processes such as neuronal plasticity, memory formation, and cell survival. CREB dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders, making it an important target for therapeutic intervention. Understanding CREB's molecular mechanisms and signaling pathways is essential for advancing research in neuroscience, oncology, and cellular biology. Researchers can utilize specific monoclonal antibodies to detect and analyze CREB expression, phosphorylation states, and protein interactions. Advanced research tools enable precise investigation of CREB's role in both normal physiological conditions and disease states. Exploring CREB's functions through immunological techniques contributes significantly to understanding cellular signaling networks and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for CREB research support scientists in making meaningful discoveries that advance our understanding of human health and disease.